Oaktree Acquisition Corp. III Life Sciences
Company Information
Industry
Blank Checks
SIC Code
6770
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
Cayman Islands
Business Address
333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES, CA, 90071
Mailing Address
333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES, CA, 90071
Phone
213-830-6300
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 26, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | October 29, 2025 | View on SEC |
| 3 Initial insider ownership report | October 29, 2025 | View on SEC |
| 3 Initial insider ownership report | October 22, 2025 | View on SEC |
| 8-K Current report of material events | October 17, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | August 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 12, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | July 15, 2025 | View on SEC |
Annual Reports
10-K
March 26, 2026
- Backed by Oaktree Capital Management, a firm with over $223 billion in assets.
- Proven track record of taking healthcare companies like Hims & Hers and Alvotech public.
Related Companies
Companies in the same industry (SIC: 6770)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.